Xi'an Travels
Release time:
2021-12-13
In February this year, I packed my bags and set off on my journey to Xi 'an. Xi'an is a city with a strong history and culture. The Big Wild Goose Pagoda, Little Wild Goose Pagoda, Datang City that never sleeps, Xi'an City Wall, Bell and Drum Tower, Huaqing Pool, Datang Furong Garden and other monuments record a strong Chinese civilization.
Xi 'an is sleeping during the day. We can go to the Shaanxi Provincial History Museum to read historical relics and feel and understand the ancient civilization that is more than 1,000 years away from us. You can also go to Xi 'an City Wall, Bell and Drum Tower and Datang Furong Garden to see the scenery where ancient dignitaries visited and lived. You can also go to Hui Min Street and try authentic Shaanxi snacks, the most authentic Shaanxi roujiamo, mutton steamed bun. In addition to the historical customs and customs, Xi'an also has the uncanny workmanship of nature. Huashan, one of the five mountains, is not far away.
As soon as the sun goes down into the night, we seem to have stepped into the tunnel of time and space. As soon as we entered the evening, the whole city seemed to come alive, allowing us to enter the ancient times directly from the modern day and return to the prosperous Tang Dynasty. When the lights of the city that never sleeps in the Tang Dynasty were turned on on the road and the city wall of Xi'an, we were like being in the heyday of the Tang Dynasty at that time, walking in history, and feeling the glory of historical civilization here.
When I came to Xi'an, I had to look at the Terracotta Warriors and Horses. When I visited the remains of the Terracotta Warriors and Horses, I seemed to feel the atmosphere of killing from the ancient Qin Kingdom, and a wind of iron and blood came to my face. The terracotta warriors and horses show the power of the Qin Dynasty, which unified China at that time, and the great talent of the first emperor of Qin, which they guarded. The lifelike Qin army seems to be coming to us at any time across the millennium.
Xi'an not only has rich history and culture, but also integrates ancient and modern times, which makes people linger and forget to go. (Ma Pengfei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31